title: Determination of the distribution of lentogenic vaccine and virulent Newcastle disease virus antigen in the oviduct of SPF and commercial hen using immunohistochemistry.
abstract: The control of Newcastle disease (ND) in South Africa has proved difficult since 2002 following the introduction of lineage 5d/VIId Newcastle disease virus (NDV) strain ("goose paramyxovirus" - GPMV) to which commercially available ND vaccines appeared less effective. Most of the ND infections, even in fully vaccinated hens were characterized consistently by a drop in egg production. In this study, commercial and SPF hens-in-lay were vaccinated with La Sota vaccine and challenged with a GPMV isolate. Immunohistochemical labeling was used to determine the distribution of viral antigen in the oviduct of the hens. Following reports that cloacal vaccination offered better protection against egg production losses than the oro-nasal route, the efficacy of cloacal and ocular routes of vaccination against challenge were compared. Results showed that La Sota vaccine offered birds 100% protection against the virulent ND (GPMV) virus challenge from clinical disease and death, but not against infection and replication of the GPMV, as birds showed varying degrees of macropathology. Histopathology of the oviduct of infected birds revealed multifocal lymphocytic inflammation in the interstitium as well as mild glandular ectasia and mild edema. Finely granular NDV-specific immunolabeling was demonstrated in the cytoplasm of epithelial cells and mononuclear (lymphohistiocytic) cells in the interstitium of the oviduct. Both vaccine and virulent GPMV showed greatest tropism for the uterus (versus the magnum and isthmus). There was no clear difference in the protection of the oviduct and in the distribution of oviductal GPMV antigens between the two routes of vaccination.
authors.affiliation: Production Animal Studies Department, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa. dgbwala@yahoo.com
authors.forename: Dauda G
authors.initials: DG
authors.lastname: Bwala
authors.forename: Sarah
authors.initials: S
authors.lastname: Clift
authors.forename: Neil M
authors.initials: NM
authors.lastname: Duncan
authors.forename: Shahn P R
authors.initials: SP
authors.lastname: Bisschop
authors.forename: Fasina F
authors.initials: FF
authors.lastname: Oludayo
mesh_terms: D000818:Animals; D000956:Antigens, Viral / Q000032:analysis*; D002645:Chickens / Q000821:virology; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D005260:Female; D009521:Newcastle Disease / Q000276:immunology / Q000473:pathology / Q000517:prevention & control* / Q000821:virology; D009522:Newcastle disease virus / Q000276:immunology; D010057:Oviducts / Q000737:chemistry / Q000473:pathology / Q000821:virology*; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D000956:Antigens, Viral; D014765:Viral Vaccines